SUVENPHAR.NS

Suven Pharmaceuticals Limited · Healthcare · Drug Manufacturers-Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$121.43B

PE Ratio

32.436318535464274

EV to Ebitda

—

Earnings Yield

255053618.39%

Revenue (TTM)

$161.3M

Net Income (TTM)

$45.8M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

-9.70%

Profit Margin

28.39%

Return on Equity

—

Debt to Equity Ratio

0.06025532255759534

Dividend Yield

0.00%

All fundamentals

Core6 fields›

Market Cap$121.43B

Revenue TTM$161.3M

Shares Outstanding254.6M

Float86504496

Insider Ownership62.37%

Institutional Ownership17.32%

Growth Estimates3 fields›

Revenue Growth (Quarterly YoY)-9.70%

EPS Growth (Quarterly YoY)-32.80%

EPS Growth Est Quarterly0

Operations14 fields›

Revenue TTM$161.3M

Gross Margin TTM55.90%

Gross Margin (Quarterly)55.62%

Operating Margin TTM38.18%

Operating Margin (Quarterly)38.01%

Profit Margin TTM28.39%

Profit Margin (Quarterly)30.45%

Net Income TTM$45.8M

EPS TTM14.89

EBIT Margin TTM41.41%

EBITDA TTM$66.8M

Capex % of Revenue TTM0.00%

Capital Expenditures$0.00M

FCF % of Revenue (Quarterly)19.09%

Efficiency1 fields›

ROA19.84%

Valuation7 fields›

P/E (TTM)32.436318535464274

P/E Forward0

EV/Revenues (TTM)8.841

Price To Book8.178634943910259

Earnings Yield255053618.39%

Dividend Yield0.00%

Payout Ratio20.15%

Liquidity6 fields›

Cash Per Share20.765879340270878

Current Ratio5.363595727885722

Total Assets$18060.16T

Shareholders Equity$15030.56T

Debt to Equity0.06025532255759534

Interest Expense$53.2M

Yields3 fields›

Dividend Yield0.00%

Payout Ratio20.15%

Earnings Yield255053618.39%